Dalton Transactions
Paper
NMR (CDCl3): δ = 75.23 ppm. HRMS (ESI, MeOH–FA): 130.64 (s, C-5′), 131.48 (d, 5J = 2.6 Hz, C-4′), 137.09 (d, 2J = 15.5
C12H10NPS (231.25), calcd for [M + H]+ 232.0344; found: Hz, Cq-1′), 141.29 (d, 2J = 6.9 Hz, Cq-7a), 141.79 (d, 1J = 40.6 Hz,
232.0345.
Cq-3a), 171.81 (d, 1J = 50.5 Hz, Cq-2) ppm. 31P{1H} NMR
Characteristic NMR (CDCl3) signals of 5-methyl-2-thienyl- (CDCl3): δ = 79.0 ppm. MS (EI 70 eV, 350 °C): m/z (%) = 306 (5),
2,3-dihydro-1,3-benzazaphosphole (4e): diastereoisomer with 305 (34), 304 (8), 303 (29) [M+], 226 (19), 149 (18), 121 (28),
1
P–H and 2-thienyl in the syn-position, δ1H = 4.49 (dd, JPH
=
91 (17), 77 (19), 57 (17), 44 (100). HRMS (ESI, MeOH–FA):
188.5, 3J = 15.0 Hz, PH), 5.55 (dd, JPH = 21.3, 3J = 15.0 Hz, C14H11BrNP (304.12), calcd for [M(79Br) + H]+ 303.9885; found
2
H-2), δ31P = −47.0 ppm; diastereoisomer with P–H and 303.9888.
2-thienyl in the anti-position, δ1H = 4.95 (dd, JPH = 185.8, J =
Synthesis of 2-(2-bromophenyl)-5-methyl-1H-1,3-benzaza-
6.6 Hz, PH), 5.67 (d, J = 6.6 Hz, JPH very small, H-2), δ31P = phosphole (2h) and 1-(2-bromobenzyl)-2-(2-bromophenyl)-5-
−58.5 ppm; syn : anti ratio 2 : 1 (based on PH integrals). methyl-1,3-benzazaphosphole (3h). o-Bromobenzaldehyde
1
3
3
2
2-(2-Methoxyphenyl)-5-methyl-1H-1,3-benzazaphosphole (0.95 mL, 8.14 mmol), 1 (750 mg, 5.39 mmol) and PTSA
(2f). o-Methoxybenzaldehyde (318 mg, 2.32 mmol) and PTSA (1.02 g, 5.36 mmol) were heated in toluene (10 mL) to reflux
(64 mg, 15 mol%) were added to 1 (310 mg, 2.23 mmol) in for 72 h, and the mixture was worked up as described for 2g.
toluene (10 mL) and heated to reflux for 48 h. Toluene was The resulting oil was separated into two products by column
removed in a vacuum, and the ethereal solution of the residue chromatography. The 1,2-disubstituted product 3h was
extracted with degassed 5% aq. NaOH. Drying with Na2SO4 obtained as a brownish yellow solid as the first fraction using
and evaporation of ether furnished 525 mg brown oil, still dis- dry 10% CH2Cl2–n-hexane as an eluent, yield 381 mg (15%).
playing aryl impurities in the NMR spectrum. Column chrom- The second fraction using dry 20% CH2Cl2–n-hexane for
atography (n-hexane, followed by 25% Et2O–hexane) gave ca. elution gave 652 mg (40%) of 2h as a brownish yellow oil.
1
250 mg (44%) of a pale yellow oil. 1H NMR (CDCl3): δ = 2.45 (s,
Data of 2h: H NMR (CDCl3): δ = 2.46 (s, 3 H, Me), 7.21 (d
3 H, Me), 4.04 (s, 3 H, OMe), 7.03 (superimposed dd, 3J = br, superimposed, J = 8.3 Hz, 1 H, H-6), 7.21–7.28 (m, super-
8.4–7, J = 1–2.5 Hz, 1 H, H-6), 7.13 (superimposed t, J = 7–8 imposed, 1 H, H-4′), 7.38 (td, J = 7.5, J = 1.2 Hz, 1 H, H-5′),
3
4
3
3
4
3
3
3
4
Hz, 1 H, H-5′), 7.17 (superimposed d, J ≈ 7.5 Hz, 1 H, H-3′), 7.54 (br d, J = 8.4 Hz, 1 H, H-7), 7.69 (dd, J = 8.0, J = 1.1 Hz,
7.32 (tdd 3J = 8.3, 7.2, 3J = 1.6, J = 0.8 Hz, 1 H, H-4′), 7.52 (d br, 1 H, H-3′), 7.76 (dt, J = 7.7, J ≈ JPH = 1.7, 1.6 Hz, 1 H, H-6′),
3
4
4
3J = 8.3 Hz, 1 H, H-7), 7.85 (ddd, 3JPH = 3.8, 4J = 1.7, 5J = 0.7 Hz, 7.86 (ddd, JPH = 3.7, J = 1.6, J = 0.8 Hz, 1 H, H-4), 9.62 (br,
3
4
5
1 H, H-4), 8.21 (ddd, J = 8.0, JPH = 4.2, J = 1.6 Hz, 1 H, H-6′), 1 H, NH) ppm. 13C{1H} NMR (CDCl3): δ = 21.25 (s, Me), 113.43
3
4
10.95 (br, 1 H, NH) ppm. 13C{1H} NMR (CDCl3, ref. solv): δ = (s, C-7), 120.85 (d, JPC = 6.7 Hz, Cq-2′), 127.31 (d, J = 3.2 Hz,
3
4
21.28 (Me), 55.27 (OMe), 112.02 (s, CH-3′), 113.47 (s, CH-7), C-6), 127.79 (s, C-5′), 128.00 (d, 2J = 20.3 Hz, C-4), 129.85 (d
121.80 (s, CH-5′), 123.17 (d, J = 14.5 Hz, Cq-1′), 126.58 (d, J = superimposed, 3J ≈ 11 Hz, Cq-5), 129.89 (s, C-4′), 132.43 (d, 3J =
2
4
2.5 Hz, CH-6), 127.65 (d, 2J = 21.4 Hz, CH-4), 129.46 (super- 12.1 Hz, C-6′), 133.91 (s, C-3′), 135.59 (d, J = 17.1 Hz, Cq-1′),
2
imposed d, 3J = 10.7 Hz, Cq-5), 129.68 (superimposed d, 3J = 22 140.71 (d, J = 6.7 Hz, Cq-7a), 141.65 (d, J = 42.4 Hz, Cq-3a),
2
1
Hz, CH-6′), 129.73 (d, J = 3.4 Hz, CH-4′), 141.07 (d, J = 40.0 172.30 (d, J = 50.4 Hz, Cq-2) ppm. 31P{1H} NMR (CDCl3): δ =
Hz, Cq-3a), 140.76 (d, 2J = 5.5 Hz, Cq-7a), 154.66 (d, 3J = 8.3 Hz, 84.3 ppm. MS (EI 70 eV, 320 °C): m/z (%) = 306 (17), 305 (100),
Cq-2′), 172.97 (d, 1J = 50.6 Hz, Cq-2) ppm. 31P{1H} NMR 304 (22), 303 (99) [M+], 224 (90), 121 (64), 77 (25). HRMS (ESI,
(CDCl3): δ = 76.1 ppm. HRMS (ESI, MeOH–FA): C15H14NOP MeOH–FA): C14H11BrNP, calcd for [M(79Br) + H]+ 303.9885,
5
1
1
(255.25), calc. for [M + H]+ 256.0886; found: 256.0886.
2-(3-Bromophenyl)-5-methyl-1H-1,3-benzazaphosphole (2g).
found 303.9889.
Data of 3h: 1H NMR (CDCl3): δ = 2.45 (s, 3 H, Me), 5.15,
m-Bromobenzaldehyde (1.06 ml, 9.09 mmol) and PTSA (1.56 g, 5.55 (2 d, 2J = 17.4 Hz, 2 H, NCHAHB), 6.21 (m, 1 H, aryl),
3
4
8.20 mmol) were added to 1 (1.13 g, 8.12 mmol) in toluene 7.01–7.04 (m, superimposed, 2 H, aryl), 7.15 (dt, J = 8.6, J ≈
(10 mL) and heated to reflux for 72 h. Toluene was removed 5JPH = 0.7 Hz, 1 H, H-6), 7.27–7.28 (m, br, 3 H, aryl), 7.33–7.39
in a vacuum, the residue dissolved in dichloromethane (m, 1 H, aryl), 7.45–7.50 (m, 1 H, aryl), 7.65–7.70 (m, 1 H, aryl),
and the catalyst extracted with 5% aq. NaOH solution. The 7.91 (br dt, JPH = 4.1, J ≈ J = 0.7 Hz, 1 H, H-4) ppm. 13C{1H}
3
4
5
3
organic phase was dried with Na2SO4 and concentrated. The and DEPT135 NMR (CDCl3): δ = 21.14 (s, Me), 50.29 (d, JPC
=
crude product 2g was purified by column chromatography, 3.5 Hz, NCH2), 113.45 (s, C-7), 121.55 (s, Cq-2″), 124.72 (d,
eluting with 20% CH2Cl2–n-hexane, to give 1.68 g (68%) of 3JPC = 6.8 Hz, Cq-2′), 127.14, 127.30 (C-4″, C-5″), 127.72 (s, C-5′),
1
a pale brownish-yellow viscous oil. H NMR (CDCl3): δ = 2.46 128.45 (d, 2J = 22.1 Hz, C-4), 128.80 (s, C-6″), 130.24 (d, 3J =
3
(s, 3 H, Me), 7.20 (d br, 3J = 8 Hz, H-6), 7.30 (t, 3J = 7.9 Hz, 1 H, 11.2 Hz, Cq-5), 130.47 (s, C-4′), 132.56 (s, C-3″), 132.74 (d, J =
6
2
H-5′), 7.48 (dtd, 3J = 7.9, 4J = 1.8, JPH = 0.8 Hz, 1 H, H-4′), 12.0 Hz, C-6′), 132.82 (s, C-3′), 135.49 (d, J = 17.4 Hz, Cq-1′),
7.52 (d, 3J = 8.5 Hz, 1 H, H-7), 7.71 (dtd, 3J = 7.8, 4J = 1.8, 4JPH
=
135.73 (s, Cq-1″), 141.02 (d, 2J = 6.5 Hz, Cq-7a), 141.83 (d, 1JPC
=
1.2 Hz, 1 H, H-6′), 7.83 (d br, JPH = 4.1 Hz, 1 H, H-4), 7.91 41.0 Hz, Cq-3a), 175.66 (d, JPC = 48.7 Hz, Cq-2) ppm. 31P{1H}
3
1
4
(q, JPH
≈
4J = 1.8 Hz, 1 H, H-2′), 9.32 (br, 1 H, NH) ppm. NMR (CDCl3): δ = 79.4 ppm. MS (EI 70 eV, 170 °C): m/z (%) =
13C{1H} and DEPT135 NMR (CDCl3): δ = 21.23 (s, Me), 475 (19), 474 (9), 473 (37), 471 (29) [M+], 394 (11), 392 (11.5),
3
113.29 (s, C-7), 123.24 (s, Cq-3′), 123.96 (d, J = 13.0 Hz, C-6′), 304 (13), 302 (14), 222 (51), 171 (72), 169 (74), 149 (100), 71
127.55 (d, 4J = 2.6 Hz, C-6), 127.86 (d, 3J = 12.2 Hz, C-2′), (48), 57 (68). HRMS (ESI, MeOH–FA): C21H16Br2NP (473.14),
128.30 (d, 2J = 21.1 Hz, C-4), 130.12 (d, 3J = 12.9 Hz, Cq-5), calcd for [M(79Br2) + H]+ 471.9460, found 471.9463.
This journal is © The Royal Society of Chemistry 2013
Dalton Trans., 2013, 42, 9523–9532 | 9529